Insider Transactions in Q1 2024 at Skye Bioscience, Inc. (SKYE)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 13
2024
|
Andrew J. Schwab Director |
BUY
Grant, award, or other acquisition
|
Indirect |
450,000
+5.09%
|
$4,500,000
$10.0 P/Share
|
Mar 13
2024
|
5 Am Partners Vii, LLC |
BUY
Open market or private purchase
|
Indirect |
450,000
+5.09%
|
$4,500,000
$10.0 P/Share
|
Feb 29
2024
|
Paul A. Grayson Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+22.41%
|
-
|
Feb 29
2024
|
Tuan Tu Diep Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+19.71%
|
-
|
Feb 29
2024
|
Kaitlyn Melanie Arsenault Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+10.61%
|
-
|
Feb 29
2024
|
Punit Dhillon Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+20.12%
|
-
|
Jan 31
2024
|
Andrew J. Schwab Director |
BUY
Grant, award, or other acquisition
|
Indirect |
5,206,074
+39.59%
|
$10,412,148
$2.31 P/Share
|
Jan 31
2024
|
5 Am Partners Vii, LLC |
BUY
Open market or private purchase
|
Indirect |
5,206,074
+39.59%
|
$10,412,148
$2.31 P/Share
|